PPMS
Your guide to Ocrevus
treatment for primary
progressive MS (PPMS)
Adrian, UK
Living with MS since 2022
On Ocrevus since 2023
Adrian, UK
Living with MS since 2022
On Ocrevus since 2023
Your guide to Ocrevus
treatment for primary
progressive MS (PPMS)
Your guide to Ocrevus
treatment for primary
progressive MS (PPMS)
Adrian, UK
Living with MS since 2022
On Ocrevus since 2023
If you’re reading this, you have primary progressive MS (PPMS) and have been prescribed Ocrevus. This website aims to provide guidance on your MS treatment, Ocrevus.
As you’ll discover from the Helpful Resources page on this website, you’re part of a strong, supportive MS community, who are here to help.
“Ocrevus has freed me up to live as normal a life as possible”
Adrian
Who has relapsing remitting MS (RRMS), on Ocrevus IV infusion
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. Please report suspected side effects to the MHRA through the Yellow Card scheme, via the Yellow card website www.mhra.gov.uk/yellowcard, or the free Yellow Card app available in the Apple App Store or Google Play Store. You should also report side effects to Roche Products Ltd. by emailing the Roche Drug Safety Centre at welwyn.uk_dsc@roche.com or calling +44 (0) 1707 367554. By reporting side effects you can help provide more information on the safety of this medicine.